Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Tenforde

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
The Cochrane Database of Systematic Reviews|July 26, 2018
Treatment for HIV-associated cryptococcal meningitisMark W Tenforde, Adrienne E Shapiro, Benjamin Rouse, et al.
Human Vaccines & Immunotherapeutics|November 10, 2021
A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeuticsKatherine Adams, Mark W Tenforde, Shreya Chodisetty, et al.
Journal of the International AIDS Society|January 21, 2020
Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysisMark W Tenforde, Alida M Gertz, David S Lawrence, et al.
Plos One|October 21, 2021
Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scaleEric J Chow, Mark W Tenforde, Melissa A Rolfes, et al.
Wellcome Open Research|March 25, 2020
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in BotswanaMark W Tenforde, Charles Muthoga, Andrew Callaghan, et al.
Wellcome Open Research|January 31, 2022
Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101-200 cells/µL in BotswanaMark W Tenforde, Charles Muthoga, Ponego Ponatshego, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024Sophie Zhu, Joshua Quint, Tomás M León, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2021
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 VaccinesJoseph A Lewnard, Manish M Patel, Nicholas P Jewell, et al.
Critical Care Explorations|March 31, 2021
Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019Tanya K Marvi, William B Stubblefield, Benjamin F Tillman, et al.
The Journal of Infectious Diseases|May 13, 2025
Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023-2024 SeasonSophie Zhu, Joshua Quint, Tomás León, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
The Cochrane Database of Systematic Reviews|July 26, 2018
Treatment for HIV-associated cryptococcal meningitisMark W Tenforde, Adrienne E Shapiro, Benjamin Rouse, et al.
Human Vaccines & Immunotherapeutics|November 10, 2021
A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeuticsKatherine Adams, Mark W Tenforde, Shreya Chodisetty, et al.
Journal of the International AIDS Society|January 21, 2020
Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysisMark W Tenforde, Alida M Gertz, David S Lawrence, et al.
Plos One|October 21, 2021
Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scaleEric J Chow, Mark W Tenforde, Melissa A Rolfes, et al.
Wellcome Open Research|March 25, 2020
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in BotswanaMark W Tenforde, Charles Muthoga, Andrew Callaghan, et al.
Wellcome Open Research|January 31, 2022
Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101-200 cells/µL in BotswanaMark W Tenforde, Charles Muthoga, Ponego Ponatshego, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024Sophie Zhu, Joshua Quint, Tomás M León, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2021
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 VaccinesJoseph A Lewnard, Manish M Patel, Nicholas P Jewell, et al.
Critical Care Explorations|March 31, 2021
Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019Tanya K Marvi, William B Stubblefield, Benjamin F Tillman, et al.
The Journal of Infectious Diseases|May 13, 2025
Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023-2024 SeasonSophie Zhu, Joshua Quint, Tomás León, et al.
Pageof 14